A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation
Crossref DOI link: https://doi.org/10.1038/s41598-021-82055-0
Published Online: 2021-01-26
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kotaki, Tomohiro
Xie, Xuping
Shi, Pei-Yong
Kameoka, Masanori
Text and Data Mining valid from 2021-01-26
Version of Record valid from 2021-01-26
Article History
Received: 29 August 2020
Accepted: 14 January 2021
First Online: 26 January 2021
Competing interests
: The authors declare no competing interests.